Risk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)

dc.creator	Papatheodoridis, G. V.	en
dc.creator	Dalekos, G. N.	en
dc.creator	Yurdaydin, C.	en
dc.creator	Goulis, I.	en
dc.creator	Arends, P.	en
dc.creator	Buti, M.	en
dc.creator	Sypsa, V.	en
dc.creator	Manolakopoulos, S.	en
dc.creator	Mangia, G.	en
dc.creator	Gatselis, N.	en
dc.creator	Keskin, O.	en
dc.creator	Savvidou, S.	en
dc.creator	Hansen, B. E.	en
dc.creator	Papaioannou, C.	en
dc.creator	Galanis, K.	en
dc.creator	Idilman, R.	en
dc.creator	Colombo, M.	en
dc.creator	Esteban, R.	en
dc.creator	Janssen, H. L.	en
dc.creator	Lampertico, P.	en
dc.date.accessioned	2015-11-23T10:44:28Z
dc.date.available	2015-11-23T10:44:28Z
dc.date.issued	2013
dc.identifier.issn	0270-9139
dc.identifier.uri	http://hdl.handle.net/11615/31948
dc.source.uri	<Go to ISI>://WOS:000330252201190
dc.subject	Gastroenterology & Hepatology	en
dc.title	Risk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)	en
dc.type	journalArticle	en

Files in this item

Files	Size	Format	View
There are no files associated with this item.